Skip to main content

Advertisement

Log in

An exploration of the impact of ethanol diluent on breath alcohol concentration in patients receiving paclitaxel chemotherapy

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to provide a better understanding of the impact of paclitaxel chemotherapy on breath alcohol in an Irish population.

Methods

Patients attending the Oncology Day Unit at Beaumont Hospital were invited to participate on the day of their treatment. The brand of paclitaxel used was Actavis Pharma Inc and contained 6 mg/mL paclitaxel in 50% Ethanol/ 50% Cremophor EL. Breath alcohol concentration was measured using the AlcoSense ™ Breathalyser on three separate visits. The primary end-point was the number of patients who were above the legal threshold for drink driving in Ireland.

Results

In total, 50 patients were recruited. 36 (68%) were female. The most common diagnosis was breast cancer (56%). Ten (20%) patients had metastatic disease and 4 (8%) had liver metastases. The mean paclitaxel dose administered was 118 mg. The mean amount of ethanol infused was 7.7 g. 27 patients had a detectable breath alcohol level on at least one visit. The mean breath alcohol concentration was 2 mcg/100 mL or 0.02 mg/L of breath. The maximum concentration of ethanol in exhaled breath was 11 mcg/100 mL or 0.11 mg/L which is 50% of the statutory limit for drink driving in Ireland. A weak correlation was observed between ethanol concentration in exhaled breath and the total amount of ethanol administered. Although no patient exceeded the general limit for drink driving in Ireland, three (6%) participants had a breath alcohol concentration above the threshold for professional, learner or novice drivers.

Conclusion

Although definitive conclusions are limited by relatively small numbers, it seems unlikely that weekly paclitaxel infusions pose any significant risk to patients driving.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author on request.

References

  1. Mukhtar E, Adhami VM, Mukhtar H (2014) Targeting microtubules by natural agents for cancer therapy. Mol Cancer Ther 13(2):275–284

    Article  CAS  Google Scholar 

  2. Donehower RC (1996) The clinical development of paclitaxel: a successful collaboration of academia, industry and the National Cancer Institute. Stem Cells 14(1):25–28

    Article  CAS  Google Scholar 

  3. Joyce C (1993) Taxol: search for a cancer drug. Bioscience 43(3):133–136

    Article  Google Scholar 

  4. Wilson DB, Beck TM, Gundlach CA (1997) Paclitaxel formulation as a cause of ethanol intoxication. Ann Pharmacother 31(7–8):873–875

    Article  CAS  Google Scholar 

  5. Aomori T, Makino H, Sekizuka M, Hashita T, Araki T, Iizuka K et al (2012) Effect of ethanol in Paclitaxel injections on the ethanol concentration in exhaled breath. Drugs R&D 12(3):165–170

    Article  CAS  Google Scholar 

  6. Komagata H, Yoneda S, Sakai H, Isobe K, Shirai T, Fujimura M et al (2006) Breath alcohol concentrations in Japanese outpatients following paclitaxel and docetaxel infusion. Int J Clin Pharmacol Res 25(4):195–202

    Google Scholar 

  7. Yamada Y, Sun F, Tsuritani I, Honda R (2002) Genetic differences in ethanol metabolizing enzymes and blood pressure in Japanese alcohol consumers. J Hum Hypertens 16(7):479–486

    Article  CAS  Google Scholar 

  8. Yagi T, Fujiishi K, Hasegawa A, Otsuka T, Yoshinami T, Nishio M et al (2019) Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients. Breast Cancer 26(2):229–234

    Article  Google Scholar 

  9. Halim IIA, Ashri ME, Sadda WE (2011) Weekly paclitaxel versus standard 3-week schedule in patients with metastatic breast cancer. J Clin Oncol 29(15 suppl):627

    Article  Google Scholar 

  10. Green MC, Buzdar AU, Smith T, Ibrahim NK, Valero V, Rosales MF et al (2005) Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. J Clin Oncol 23(25):5983–5992

    Article  CAS  Google Scholar 

  11. Generics T. Generic of taxol® injection 2007 https://www.tevagenerics.com/product/paclitaxel-injection-usp

  12. Author N. https://www.medicines.org.uk/emc/files/pil.3891.pdf

  13. NICE CfPHE. Review of effectiveness of laws limiting blood alcohol concentration levels to reduce alcohol-related road injuries and deaths March 2010. http://www.ias.org.uk/uploads/pdf/bloodalcoholcontenteffectivenessreview.pdf

  14. Authority RS. Drink driving in Ireland 2018. https://www.drinkdriversdestroylives.ie

  15. Library HND. New drink driving limits and penalties in Ireland. 2011. https://www.drugsandalcohol.ie/16883/

  16. Author N. https://www.ndls.ie/licence-categories.html

  17. Sacco JJ, Botten J, Macbeth F, Bagust A, Clark P (2010) The average body surface area of adult cancer patients in the UK: a multicentre retrospective study. PLoS ONE 5(1):e8933

    Article  Google Scholar 

  18. Jones AW (2010) The relationship between blood alcohol concentration (BAC) and breath alcohol concentration (BrAC): a review of the evidence. Road Safety Web Publication 15:1–43

    Google Scholar 

  19. Brunton LL, Lazo J, Parker KL (2011) Goodman and Gilman’s the pharmacological basis of therapeutics, 11th edn. Mc Graw-Hill, New York, pp 591–609

    Google Scholar 

  20. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW et al (2001) Gender differences in pharmacokinetics of alcohol. Alcoholism Clin Exp Res 25(4):502–507

    Article  CAS  Google Scholar 

  21. Moskowitz H, Fiorentino D (2000) A review of the literature on the effects of low doses of alcohol on driving-related skills. Report No: DOT HS 809 028. National Highway Traffic Safety Administration, Washington, DC

Download references

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by RJK, MM, KB, KE, LG, PGM, OSB. The first draft was written by RK and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to R. J. Keogh.

Ethics declarations

Conflict of interest

Travel support: Patrick G. Morris, Roche, Novartis, Amgen; Honoraria: Patrick G. Morris, Astellas, Novartis, Pfizer, Teva, Nordic 2013, Bristol Meyers Squibb, Astra Zeneca, Genomic health, Roche; Consultancy or Advisory role: Patrick G. Morris, Novartis, Speaker Role: Patrick G. Morris, Teva; Research funding: Patrick G. Morris, Teva, Genomic Health.

Ethical approval

This study was approved by the Beaumont Hospital Institutional Review Board prior to study initiation. This study was performed in accordance with the Internal Conference on Harmonisation (ICH) for Good Clinical Practice (GCP) and the ethical principles founded in the Declaration of Helsinki.

Informed consent

All patients gave written informed consent to participate in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Keogh, R.J., Milewski, M., Browne, K. et al. An exploration of the impact of ethanol diluent on breath alcohol concentration in patients receiving paclitaxel chemotherapy. Cancer Chemother Pharmacol 88, 307–312 (2021). https://doi.org/10.1007/s00280-021-04279-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-021-04279-1

Keywords

Navigation